Boston Scientific has listed its 24-acre Minnetonka, Minnesota campus for sale as part of a strategic expansion in Maple Grove, another Minneapolis suburb located approximately 10 miles north.
This move represents a significant shift in the company's real estate portfolio management strategy.
Minnetonka Campus Overview
The Minnesota Star Tribune was first to report the campus listing. The property, which has been home to Boston Scientific operations since the 1980s, underwent a major redevelopment in 2013.
Campus Size
225,900 sq ft
Specialized space
Property Size
24 Acres
Minnetonka location
The campus features finished laboratories, offices, and warehouse facilities that have primarily served medical device manufacturing operations. Adding to its appeal, the site is strategically positioned near a planned station for Minneapolis's Metro Green Line Extension, scheduled to begin operations in 2027.
Strategic Transition to Maple Grove
The company confirmed that existing positions at the Minnetonka site will transition to an expanded campus on Weaver Lake Road in Maple Grove during the first half of 2026.
Initial Expansion
- 52,000 square foot expansion
- Construction currently underway
- Weaver Lake Road location
- First half 2026 completion
Future Plans
- Double campus facilities
- 170,000 square feet total
- Enhanced operational capacity
- Modern workspace design
"Across Boston Scientific we continuously align our real estate and workspace to support our business strategy as well as our growth."
Larger Development Project
This real estate consolidation aligns with an even larger development project - a 400,000 square foot divisional headquarters campus in Maple Grove, situated near the intersection of Interstate 694 and U.S. 169, which is expected to open this year.
Divisional Headquarters
400,000 sq ft
Expected to open this year
Strong Business Performance
The expansion initiatives come at a time when Boston Scientific is experiencing remarkable success with its cardiology product line, particularly the Farapulse pulsed field ablation system for AFib treatment and the Watchman LAA closure device.
Company leadership, including the CEO and executive team, expressed confidence in April regarding continued growth prospects, despite ongoing U.S. trade tensions. The company maintains an optimistic outlook, projecting 17% sales growth for the current year.
Significant Minnesota Presence
The company's significant presence in Minnesota has become increasingly noteworthy. With approximately 10,000 of its 53,000 global employees based at facilities in Maple Grove and Arden Hills within the Minneapolis-St. Paul metropolitan area, the Massachusetts-headquartered company has established a substantial footprint in the region.
Global Workforce
53,000 employees worldwide
Minnesota Workforce
10,000 employees in Minnesota
This strong regional presence prompted the Star Tribune to playfully suggest earlier this year that the company was transforming into "Minnesota Scientific."
Strategic Impact & Future Vision
The strategic consolidation and expansion in Maple Grove demonstrate Boston Scientific's commitment to optimizing its operational footprint while maintaining robust growth. The move reflects broader trends in corporate real estate strategy, where companies are increasingly focused on creating efficient, modern workspaces that support collaboration and innovation while maintaining operational excellence.
The relocation of operations from Minnetonka to Maple Grove represents more than just a change of address - it signifies a strategic investment in creating state-of-the-art facilities that will support the company's continued growth and innovation in the medical device sector.
This real estate transformation aligns with Boston Scientific's broader corporate strategy of maintaining leadership in medical device innovation while optimizing operational efficiency. The company's significant investment in Minnesota facilities underscores its commitment to the region as a key hub for research, development, and manufacturing operations.

The Boston Scientific campus in Minnetonka, Minnesota. [Image courtesy of CBRE]